Challenges in Perinatal Psychopharmacology

Katherine L. Wisner, M.D., M.S.

Introduction

Katherine L. Wisner obtained her M.S. in Nutrition and an M.D. from Case Western Reserve University, followed by a categorical pediatric internship and general and child psychiatry residency at Children’s Hospital of Pittsburgh and Western Psychiatric Institute and Clinic.  She completed a post-doctoral fellowship in Epidemiology at the University of Pittsburgh Graduate School Of Public Health, a fellowship in Professional Ethics at Case Western Reserve University in 1996, and a certificate for the Physician Leadership and Management Program at the Katz Graduate School of Business at the University of Pittsburgh. Dr. Wisner is board-certified in general and child and adolescent psychiatry. 

Dr. Wisner's main focus is research related to the psychiatric treatment of women of childbearing age. She is internationally recognized as an expert in the treatment of mood disorders during pregnancy and the postpartum period.  She has been the principal investigator on multiple National Institute of Health- and foundation-funded research projects.  Dr. Wisner and colleagues Drs. Catherine Stika and Alfred George received funding from NICHD to participate in the Obstetric-Fetal Pharmacology Research Centers.  Her memberships in scientific societies include the Organization of Teratology Information Specialists, the Teratology Society, and the North American Society for Psychosocial Obstetrics and Gynecology.  She is a Fellow of the American College of Neuropsychopharmacology and a Distinguished Life Fellow of the American Psychiatric Association.  Dr. Wisner is a past president of the Marcé International Society for Perinatal Mental Health.  She was a consultant for the U.S. CDC’s Treating for Two:  Safe Medication Use in Pregnancy; the FDA Drug Safety and Risk Management Advisory Committee on Perinatal Depression.  She has authored more than 225 peer-reviewed articles and 19 book chapters.  She received the Woman in Science Award from the American Medical Women’s Association in 2011 and the Alexandra Symonds Award from the American Psychiatric Association in 2012.  Dr. Wisner was awarded the Distinguished Mentor Award from the Institute for Clinical Research Education, University of Pittsburgh School of Medicine in 2012.  She received the Marcè International Society for Perinatal Mental Health’s Medal for lifetime contributions to the field of Perinatal Psychiatry, and is the inaugural president of the North American Society for Perinatal Mental Health.  Dr. Wisner serves on the Editorial Board of the American Journal of Psychiatry and the Journal of Clinical Psychiatry.  She received the annual APA Award for Research at the meeting in May 2017. Dr. Wisner is in the Northwestern Public Voices Fellowship, which supports faculty to write op-eds that will enhance the impact of faculty research. 

Dr. Wisner is the founding president of the Perinatal Mental Health Association of North America, and she hosted a meeting in November 2017 that drew 425 registrants, a testimony to the public health significance of perinatal mental health! 

Learning Objectives

1. Discuss a synthsis of the impact of pregnancy on the course of major mood disorders.
2. Discuss pharmacologic and non-pharmacologic strategies for managing mood disorders durin gpregnancy and postpartum.

Live webcast available at: http://videos.mayo.edu/live
1 AMA PRA Category 1 Credit(s)™ hour is offered for watching this Webcast live. Ethos will be implemented for all post presentation surveys. To document your attendance, please text the code given at the presentation to 507-200-3010. For questions, email rstpsychgr@mayo.edu.

Accreditation Statement

In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s)

AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

APA
The Department of Psychiatry and Psychology at Mayo Clinic, Rochester, is approved by the American Psychological Association to sponsor continuing education credits for psychologists. The Department of Psychiatry and Psychology at Mayo Clinic, Rochester maintains responsibility for this program and its content.

Archived webcast available at: Psychiatry & Psychology Video Library

Industry Acknowledgment (if applicable): None.

All participants MUST complete the evaluation in order to get CME or APA Credit.

1) Text the CODE announced at the session within 48 hours to (507) 200-3010
2) Login at ce.mayo.edu and go to My Account, My Courses, Registered Courses, click Session title and START to access the required Evaluation.
-or-
Click the START button on that session page.
3) Evaluation must be completed within 2 weeks.

Disclosure Summary
As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science (Mayo Clinic School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.
 

Listed below are individuals with control of the content of this program who have disclosed…

Relevant financial relationship(s) with industry:

Mark Frye, M.D. - Mayo Clinic

Grant Support: AssureRx, Janssen R&D, Myriad, Pfizer Consultant: Janssen R&D, Mitsubishi Tanabe Pharma Corp., Myriad Genetics, Sunovion, Supernus Pharmaceuticals, Teva Pharmaceuticals, Neuralstem, Inc.

CME/Travel: American Physician Institute, CME Outfitters

Speaker:  Katherine L. Wisner, M.D., M.S.
Grant Support:  NIHCD
Honoraria:  2020MOM, Virginia Commonwealth University
Consultant:  Allegheny Health Network

No relevant financial relationship(s) with industry:
Kriti Gandhi, M.D., Allison Holgerson, Ph.D., Matej Markota, M.D., Charlene Nelson, Reem Shafi, M.B.B.S., Laura Suarez, M.D.

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None